CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 79 enrolled
Drug / intervention
Injeq Bioimpedance Probe (BIP) Needledevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02605928
NCT02605928N/ACompleted
CompareCT.gov

INJ-INAR-01 Use of BIP-Needles in Rheumatologic Injections

Injeq Ltd·interventional·Posted Nov 17, 2015·Updated Apr 4, 2017

In Brief

A clinical study evaluating Injeq Bioimpedance Probe (BIP) Needle for Intra-articular Injections. Completed, enrolled 79 participants across 1 site.

Detailed Summary

The study focuses on needle guidance in rheumatologic operations - glucocorticoid injections inside joint capsules specifically. The main purpose of the study is to assess and validate the clinical feasibility and performance of Bioimpedance Probe (BIP) Needles and assess the benefits, drawbacks and risks related to use of the BIP Needles.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntra-articular Injections
CountriesFinland
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedNov 17, 2015
Enrollment StartOct 1, 2014
Primary CompletionMay 1, 2015
Study CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 10.6 years ago

Interventions

Injeq Bioimpedance Probe (BIP) Needledevice

Injeq Bioimpedance Probe (BIP) Needle is an injection needle that has bioimpedance measurement capability. It consists of traditional needle cannulae and removable bioimpedance probe which enables the measurement of bioimpedance. The needle is connected to measurement device and tissue identifying algorithm. Bioimpedance is measured during the operation and the algorithm detects when the needle tip is in contact with synovial fluid.